042520 — HANS BIOMED Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapSucker Stock

Annual cashflow statement for HANS BIOMED, fiscal year end - September 30th, KRW millions except per share, conversion factor applied.

	2020 September 30th	2021 September 30th	2022 September 30th	2023 September 30th	2024 September 30th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-18,171	-22,126	4,923	-24,092	-7,800
Depreciation
Amortisation
Non-Cash Items	28,194	2,687	-6,915	21,874	10,222
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-9,069	-818	-7,180	-6,714	-6,049
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities	4,567	-15,472	-4,270	-3,733	1,759
Capital Expenditures	-7,973	-5,208	-4,134	-2,067	-2,829
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	6,843	-15,983	7,301	5,387	-3,766
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities	-1,130	-21,190	3,167	3,320	-6,595
Financing Cash Flow Items	339	1,204	864	1,053	0
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	61.2	29,738	1,387	-829	5,865
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	3,436	-6,790	473	-1,392	1,128